UC Hastings Law Hosts Screening of New Documentary Film: “When Rules Don’t Apply” About the Historic High-Tech Antitrust Employment Lawsuit

When Rules Don’t Apply Film

The half-hour film includes interviews with Lieff Cabraser Antitrust & Employment Law partner Dean Harvey on the civil Apple/Google/Intel et al. lawsuit initiated by our firm

UC Hastings College of the Law along with Filmmakers Collaborative and Tech Workers Coalition will be hosting a screening of the new documentary, “When Rules Don’t Apply,” a film highlighting the recent groundbreaking antitrust employment case brought by Lieff Cabraser and its co-counsel against Google, Apple, Intel, eBay and other major Silicon Valley hi-tech players over their illegal suppression of employee wages and improper restrictions on employee mobility. The screening will be followed by a panel discussion on “A New Role for an Old Rule: Antitrust in the 21st Century,” moderated by Professor Veena Dubal of UC Hastings College of the Law and featuring experts from the film including Lieff Cabraser partner Dean M. Harvey, along with other distinguished guests.  The event will take place on Thursday, May 30th from 6:00-9:00 pm at the UC Hastings Alumni Reception Center in San Francisco. [Read more…]

New Film ‘When Rules Don’t Apply’ Spotlights Successful Antitrust Challenges to Illegal High-Tech Labor Practices

When Rules Don’t Apply Film

Half-hour film includes commentary from Lieff Cabraser Antitrust & Employment Law partner Dean Harvey on the civil Apple/Google/Intel et al. lawsuit initiated by our firm

In the wake of the successful and precedent-setting lawsuit against numerous tech giants of Silicon Valley, David Donnenfield of Full Frame Productions and Kevin White of Filmmakers Collaborative SF have released “When Rules Don’t Apply,” a new short film highlighting the pivotal legal antitrust actions brought by Lieff Cabraser and its co-counsel against Google, Apple, eBay and other major hi-tech players over the illegal suppression of employee wages and restrictions on employee mobility. [Read more…]

Dean Harvey Speaks on Predatory California Bail Bonds Litigation at California Public Defenders Association Seminar

Dean Harvey Speaks on Predatory California Bail Bonds Litigation at California Public Defenders Association Seminar

Lieff Cabraser partner Dean M. Harvey will be speaking at the California Public Defenders Association (CPDA) “New Statutes” seminar taking place on March 29, 2019 at the Hilton Garden Inn in Emeryville, California. Dean’s talk is titled, “The Newly-Filed Lawsuit Challenging Unfairly High Non-Refundable Premiums Charged for Bail Bonds.” [Read more…]

Lieff Cabraser and Public Interest Groups Bring Lawsuit Alleging Insurance Companies Conspired to Inflate California Bail Bond Premiums

Lawsuit Brought by Lieff Cabraser and Public Interest Groups Contends Insurance Companies Conspired to Inflate Bail Bond Premiums

Suit filed on behalf of thousands of Californians alleges conspiracy in the bail industry to fix prices and inflate bail bond premiums, making it more difficult for people to afford bail

SAN FRANCISCO — In a first-of-its-kind class action lawsuit filed today in California Superior Court, the law firm of Lieff Cabraser Heimann & Bernstein, LLP, Justice Catalyst, Public Counsel, the National Consumer Law Center, and Towards Justice allege that an antitrust conspiracy has fixed the prices of the premiums paid for commercial bail bonds since at least 2004. [Read more…]

Dean Harvey to Speak on the Latest Developments in No-Poach Agreements at the California Lawyers Association (CLA)

DMH to Speak at CLA No Poach Program

Lieff Cabraser partner Dean M. Harvey will be featured as a distinguished speaker at the “Latest Developments in No-Poach Agreements” program taking place at the California Lawyers Association (CLA) on January 29, 2019 from 12:00pm,-1:00pm. The program is being put together by the Antitrust, UCL & Privacy Section and the Labor & Employment Section of the CLA and will feature the following: [Read more…]

Lieff Cabraser & Co-Counsel Announce Elite Swimmers, Pro Swimming League, Sue FINA Over Antitrust Violations

Woman swimming in pool

Lawsuit alleges FINA leverages its market dominance to extract—and largely keep for itself—enormous revenues from the labor of the world’s best swimmers

 SAN FRANCISCO—(BUSINESSWIRE)—A pair of top U.S. swimmers and a top Hungarian swimmer filed a class-action lawsuit today against Fédération Internationale de Natation (“FINA”), the international organization that controls access to the Olympic Games and World Championships, over its threats to ban swimmers from the Olympic Games if they compete in events that FINA does not pre-approve. [Read more…]

Settlement Reached in Antitrust Suit Against Atrium Health (fka Carolinas HealthCare)

hospital health care

The Department of Justice and the state of North Carolina have reached a settlement agreement with Atrium Health, formerly known as Carolinas HealthCare System, in a federal lawsuit alleging the hospital giant violated antitrust laws and drove up patient healthcare costs

As reported by The Charlotte Observer, the 2016 lawsuit against Atrium Health, a billion dollar hospital chain and North Carolina’s largest health care provider, alleged that the company illegally reduced competition in the local healthcare market and set consumer prices so high that many patients were left struggling with bills they could not pay. While Atrium consistently raised costs for consumers, their top execs were receiving millions of dollars.   [Read more…]

Lieff Cabraser Partner Dean Harvey Discusses the Expansion of Antitrust Law to the Employment Setting

Dean Harvey on Antitrust and Employment Cases

Workers are recovering millions after challenging illegal anticompetitive “no-poach” agreements between companies that restrict employee mobility and depress salaries. Dean Harvey, plaintiff attorney and partner at Lieff Cabraser, provides detail on the successful 2015 “High Tech” Employees class action suit against Apple, Google, Intel, Adobe, and industry giants that resulted in a settlement valued at $435 million, the largest resolution in history of antitrust claims in the employment setting, on either an aggregate or per-class-member basis. [Read more…]

Plaintiffs Defeat Motion to Dismiss in Restasis Antitrust Litigation Against Allergan

Eye Drops

As reported in Law360 (subscription), plaintiffs in the multidistrict litigation against pharmaceutical manufacturer Allergan have successfully defeated a motion to dismiss the case alleging antitrust violations with respect to the sale and marketing of dry-eye drug Restasis. The Court’s ruling favored a group of pharmaceutical purchasers and union benefit plans accusing Allergan of misconduct intended to limit competition from generic drugs. [Read more…]

Dean Harvey to Speak on Anticompetitive Practices in the Labor Market at Harvard Law School

Dean Harvey to Speak on Anticompetitive Practices in the Labor Market at Harvard Law School

Lieff Cabraser partner Dean M. Harvey will be featured as a distinguished speaker at the “Unrigging the Market: Convening to Restore Competitive Labor Markets” program, taking place at Harvard Law School on June 13, 2018 from 8:30am-4:30pm ET. He will be participating in the panel titled “Anticompetitive Practices in the Labor Market.” [Read more…]

Dean Harvey and Lin Chan Featured at BASF Antitrust for HR Seminar

Lieff Cabraser Attorneys Featured at BASF Antitrust for HR Seminar

Lieff Cabraser attorneys Lin Y. Chan and Dean M. Harvey spoke at the Bar Association of San Francisco’s Antitrust for HR: No-Poach and Wage Fixing Agreements seminar on January 16, 2018. Ms. Chan moderated the panel, and Mr. Harvey participated in the discussion. [Read more…]

Law360 Rising Star Profile: Lieff Cabraser’s Lin Chan

Law360 Rising Star Profile: Lieff Cabraser’s Lin Chan

Law360 has published an in-depth profile of Lieff Cabraser partner Lin Y. Chan, named a Law360 Rising Star for 2017 for Competition. The profile highlights Ms. Chan’s biggest case to date (illegal non-compete agreements over the blockbuster antibiotic Cipro), where she gets her motivation, how she became a competition and antitrust attorney, and the advice she would give to young attorneys striving to be successful in the law. [Read more…]

Noncompete Clauses Keep Workers Locked In

Noncompete Clauses Keep Workers Locked In

The use of noncompete clauses in employment contracts has grown enormously. Designed to prevent employees from leaving for a competitor, noncompete agreements also work to bind employees to one company, ultimately making it more difficult for them to get ahead. As noted by the New York Times, this reflects “a broad shift in which companies assert ownership over work experience as well as work,” and the paper further notes that employment lawyers see noncompete agreement usage “exploding.” [Read more…]

Carolinas HealthCare Anti-Competition Lawsuit Allowed to Proceed

Carolinas HealthCare Anti-Competition Lawsuit Allowed to Proceed

As reported by The Charlotte Observer, North Carolina Business Court Judge Michael Robinson has denied the Carolinas HealthCare System’s motion to dismiss a lawsuit accusing the hospital giant of driving up health care costs through illegal efforts to prevent competition. The lawsuit, filed by Lieff Cabraser and co-counsel in September of 2016, accuses CHS of placing improper contract restrictions on insurers forbidding them from guiding customers to lower-cost competing hospitals. [Read more…]

New Measure That Will Reshape Class Action Lawsuits Under Senate Review

New Measure That Will Reshape Class Action Lawsuits Under Senate Review

A new bill seeking to curb enforcement of U.S. class action lawsuits is facing opposition from antitrust groups, including the Committee to Support the Antitrust Laws (COSAL). The measure, H.R. 985 – Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017, is currently under review by the Senate Judiciary Committee after being passed by the House on a 220-201 vote March 9. The bill would add preconditions for class actions and complex litigation cases. [Read more…]

Dean Harvey Comments on Valeant-Kadmon Pharma Antitrust Challenges

Dean Harvey Comments on Valeant-Kadmon Pharma Antitrust Challenges

Reuters has published a compelling analysis of ongoing challenges facing pharmaceutical “rogue” Valeant with a focus on its price-inflated drug Syprine and its relationship with also-beleagured pharma company Kadmon. Among other issues, Valeant has been singled out as a prime offender in the realm of hyper-inflated pharmaceutical drugs, with, Syprine, its life-saving Wilson’s disease liver ailment treatment costing some patients nearly $300,000 for a year’s use (in 2011, Valeant priced the drug at less than $1,000 for 100 capsules, a rate that rose by 2015 to over $21,000 for the same dose). [Read more…]

Dean Harvey on the 5 Writing Mistakes Antitrust Lawyers Should Avoid

Dean Harvey on the 5 Writing Mistakes Antitrust Lawyers Should Avoid

Lieff Cabraser partner Dean M. Harvey spoke with Law360 to offer advice to antitrust lawyers on “five writing mistakes that can tilt the balance against your antitrust clients.” Along with Hausfeld LLP’s Scott Martin and Daniel Francis of Hunton & Williams, Mr. Harvey was tapped by the legal journal for his knowledge and expertise in the face of an inherent problem for antitrust attorneys created by “the complexity of competition law [which] puts them at a heightened risk of hurting their chances of victory by writing briefs that judges struggle to read.” [Read more…]